Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06138249 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Cholecalciferol and Calcifediol Are Both Useful to Improve Vitamin D Serum Levels

Study acronym: VITD
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 25, 2025 (before its estimated December 30, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Nov 30, 2024 to Dec 30, 2025
    • Study completion date: Dec 30, 2024 to Dec 30, 2025
    v4
  2. Primary completion date: Mar 30, 2024 to Nov 30, 2024
    • Study completion date: Jun 30, 2024 to Dec 30, 2024
    v3
  3. Primary completion date: Dec 30, 2023 to Mar 30, 2024v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Patients with hypovitaminosis D are randomized into three arms of treatment: Group A: Calcifediol 0,266mg each month Group B: Cholecalciferol 25000UI each 15 days Group C: Calcifediol 4 drops per day. Serum levels of vitamin D are dosed after one month of treatment
Trial Details
NCT Number NCT06138249
Lead Sponsor Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Collaborators: Silvana De Giorgi, Davide Bizzoca, Angela Notarnicola
Conditions
(from sponsor)		 Hypovitaminosis D
Related terms Vitamin D Deficiency
Enrollment 90 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov